News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tammenoms Bakker Juliet
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Sold 18,484 shares
@ $30.0635, valued at
$555.7k
Sold 14,651 shares
@ $29.0681, valued at
$425.9k
|
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 497,150 shares
@ $0
Acquired 32,950 shares
@ $0 |
|
| 06/16/2023 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 267,300 shares
@ $0
Acquired 1,022 shares
@ $0
Acquired 439 shares
@ $0 |
|
| 05/31/2023 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Disposed of 497,150 shares
@ $0
Acquired 33,135 shares
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2023 |
4
| Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 1,714,285 shares
@ $7, valued at
$12M
|
|
| 06/03/2022 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 10,349 shares
@ $0 |
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,355,000 shares
@ $3.69, valued at
$5M
|
|
| 04/05/2022 |
4
| Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 333,333 shares
@ $15, valued at
$5M
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,477,125 options to buy
@ $13.2, valued at
$19.5M
|
|
| 08/05/2021 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Bought 12,500 shares
@ $16, valued at
$200k
Converted 1,863,613 shares
@ $0
Bought 125,000 shares
@ $16, valued at
$2M
Bought 500,000 shares
@ $16, valued at
$8M
Converted 1,613,423 preferred shares
@ $0
Converted 242,013 preferred shares
@ $0
Exercised 36,302 warrants
@ $12.4, valued at
$450.1k
Exercised 36,302 preferred shares
@ $0
Paid exercise price by delivering 28,125 preferred shares
@ $0
Converted 8,177 preferred shares
@ $0 |
|
| 08/02/2021 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 5,859 shares
@ $0 |
|
| 07/29/2021 |
3
| Tammenoms Bakker Juliet (Director) has filed a Form 3 on RxSight, Inc. |
| 07/20/2021 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 3,344,038 shares
@ $0
Bought 150,000 shares
@ $20, valued at
$3M
Converted 8,774,007 options to buy
@ $0
Converted 5,654,529 options to buy
@ $0
Converted 2,291,665 options to buy
@ $0
Converted 2,500,000 options to buy
@ $0.01, valued at
$25k
Converted 500,000 warrants
@ $0.05, valued at
$25k
Converted 645,160 options to buy
@ $0.01, valued at
$6.5k
Converted 129,032 warrants
@ $0.05, valued at
$6.5k
|
|
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2021 |
4
| Tammenoms Bakker Juliet (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0
Acquired 1,504 shares
@ $0
Acquired 3,508 shares
@ $0 |
|
| 05/18/2021 |
4
| Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Converted 2,187,504 shares
@ $0
Bought 909,090 shares
@ $11, valued at
$10M
Converted 2,187,504 preferred shares
@ $0 |
|
| 05/13/2021 |
3
| Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 3 on Vera Therapeutics, Inc. |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.|
Txns:
| Disposed of 850,000 shares
@ $0
Acquired 2,973 shares
@ $0
Acquired 2,080 shares
@ $0
Acquired 891 shares
@ $0 |
|
| 10/22/2020 |
4
| Tammenoms Bakker Juliet (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Converted 3,685,358 shares
@ $0
Bought 233,333 shares
@ $18, valued at
$4.2M
Converted 3,685,358 preferred shares
@ $0 |
|
| 10/19/2020 |
4
| Tammenoms Bakker Juliet (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Granted 6,666 options to buy
@ $18, valued at
$120k
|
|
| 10/15/2020 |
3
| Tammenoms Bakker Juliet (10% Owner) has filed a Form 3 on Eargo, Inc. |
| 09/22/2020 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 9,167 shares
@ $42.666, valued at
$391.1k
|
|
| 09/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2020 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 3,500 shares
@ $0 |
|
| 08/18/2020 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 2,393 shares
@ $43.2186, valued at
$103.4k
|
|
| 08/12/2020 |
4
| Tammenoms Bakker Juliet (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Disposed of 978,000 shares
@ $0
Acquired 1,026 shares
@ $0
Acquired 2,393 shares
@ $0 |
|
|
|
|